Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cellular Dynamics International Inc.

Division of Fujifilm Holdings Corp.
www.cellulardynamics.com

Latest From JCR Pharmaceuticals Co. Ltd.

Curative Regenerative Medicines: Preparing Health Care Systems For The Coming Wave

We may be at the dawn of a new era of curative regenerative therapies, but their inherent nature may create barriers to adoption. The Alliance for Regenerative Medicine frames the opportunities and challenges for the industry, arguing that policy makers must begin to understand the ways that these therapies represent value for money.

Regenerative Medicine BioPharmaceutical

Cellvation Tackling Traumatic Brain Injuries With Stem Cell Therapy

Emerging Company Profile: With mononuclear stem cell therapy from University of Texas research, new company hopes to address traumatic brain injury by reducing the pro-inflammatory cytokine cascade, which exacerbates the initial injuries in severe TBI.

Regenerative Medicine Business Strategies

PIPELINE WATCH: Five Approvals, Six Filings And One Launch

This week's Pipeline Watch, a snapshot of all the late-stage R&D and regulatory events in the pharma and biotech industries, is now available to view.

Research & Development Pipeline Watch

Japan Phase III Start Cements Roxadustat’s Lead

Astellas/FibroGen's oral candidate for anemia in chronic kidney disease has moved into Phase III in Japan on the basis of promising Phase II results, cementing the global development lead for the first-in-class product and taking it closer to a potentially big market.

Research & Development Japan
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • ADMET
  • Pharmaceuticals
  • Services
  • Therapeutic Areas
  • Cardiovascular
  • Hepatic (Liver)
  • Neurology, Nervous System
  • Alias(es)
  • iPS Cells Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Fujifilm Holdings Corp.
  • Senior Management
  • Kazuyoshi J Hirao , Chmn. & CEO
    Timothy Daley, VP, CFO
    Emile F Nuwaysir, PhD, Pres. & COO
    Chris Parker, EVP, Chief Bus. Officer
    Nicholas J Seay , VP, Chief Tech. Officer
  • Contact Info
  • Cellular Dynamics International Inc.
    Phone: (608) 310-5100
    525 Science Dr.
    Madison, WI 53711
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register